• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全印度医学科学研究所针对1个月至18岁儿童神经运动障碍的改良国际临床流行病学网络诊断工具的开发。

Development of All India Institute of Medical Sciences-Modified International Clinical Epidemiology Network Diagnostic Instrument for Neuromotor Impairments in Children Aged 1 Month to 18 Years.

作者信息

Gulati Sheffali, Patel Harsh, Chakrabarty Biswaroop, Dubey Rachana, Arora N K, Pandey R M, Paul Vinod K, Ramesh Konanki, Anand Vyshakh, Meena Ankit

机构信息

Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

INCLEN Trust, New Delhi, India.

出版信息

Front Public Health. 2017 Nov 21;5:313. doi: 10.3389/fpubh.2017.00313. eCollection 2017.

DOI:10.3389/fpubh.2017.00313
PMID:29209604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5702309/
Abstract

INTRODUCTION

There is shortage of specialists for the diagnosis of children with neuromotor impairments (NMIs), especially in resource limited settings. Existing International Clinical Epidemiology Network (INCLEN) instrument for diagnosing NMI have been validated for children aged 2-9 years. The current study modified the same including wider symptomatology and age group (1 month to 18 years).

METHODS

The Modified INCLEN diagnostic tool (INDT) was developed by a team of experts by modifying the existing tool to widen the age range (1 month to 18 years) and include broader symptomatology (inclusion of milestones from the first 2 years of life and better elucidation of cerebellar and extrapyramidal features) in a tertiary care teaching hospital of North India between January and April 2015. A trained medical graduate applied the candidate tool, which was followed by gold standard evaluation by a Pediatric Neurologist (both blinded to each other).

RESULTS

A total of 197 children (102 with NMI and 95 without NMI) were enrolled for the study. The sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratio of the modified NMI tool were 90.4% (82.6-95.5), 95.5% (88.7-98.7), 95.5% (88.9-98.7), 90.3% (82.4-95.5), 19.9 (12.1-32.6), and 0.13 (0.08-0.12), respectively.

CONCLUSION

The All India Institute of Medical Sciences modified INDT NMI tool is a simple and structured instrument covering a wider symptomatology in the 1 month to 18 years age group with acceptable diagnostic accuracy.

摘要

引言

诊断患有神经运动障碍(NMI)的儿童的专科医生短缺,尤其是在资源有限的地区。现有的国际临床流行病学网络(INCLEN)诊断NMI的工具已在2至9岁儿童中得到验证。当前的研究对该工具进行了修改,使其涵盖更广泛的症状学和年龄组(1个月至18岁)。

方法

2015年1月至4月期间,在印度北部的一家三级医疗教学医院,一个专家团队通过修改现有工具开发了改良的INCLEN诊断工具(INDT),以扩大年龄范围(1个月至18岁)并纳入更广泛的症状学(纳入生命最初2年的发育里程碑,并更好地阐明小脑和锥体外系特征)。一名经过培训的医学毕业生应用该候选工具,随后由一名儿科神经科医生进行金标准评估(双方均不知情)。

结果

共有197名儿童(102名患有NMI,95名未患有NMI)参与了该研究。改良后的NMI工具的敏感性、特异性、阳性和阴性预测值、阳性和阴性似然比分别为90.4%(82.6 - 95.5)、95.5%(88.7 - 98.7)、95.5%(88.9 - 98.7)、90.3%(82.4 - 95.5)、19.9(12.1 -

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f971/5702309/bf3c8ef2ed58/fpubh-05-00313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f971/5702309/bf3c8ef2ed58/fpubh-05-00313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f971/5702309/bf3c8ef2ed58/fpubh-05-00313-g001.jpg

相似文献

1
Development of All India Institute of Medical Sciences-Modified International Clinical Epidemiology Network Diagnostic Instrument for Neuromotor Impairments in Children Aged 1 Month to 18 Years.全印度医学科学研究所针对1个月至18岁儿童神经运动障碍的改良国际临床流行病学网络诊断工具的开发。
Front Public Health. 2017 Nov 21;5:313. doi: 10.3389/fpubh.2017.00313. eCollection 2017.
2
Development and validation of AIIMS modified INCLEN diagnostic instrument for epilepsy in children aged 1 month-18 years.全印医学科学研究所(AIIMS)改良的1至18岁儿童癫痫INCLEN诊断工具的开发与验证
Epilepsy Res. 2017 Feb;130:64-68. doi: 10.1016/j.eplepsyres.2017.01.008. Epub 2017 Jan 25.
3
INCLEN Diagnostic Tool for Neuromotor Impairments (INDT-NMI) for primary care physician: development and validation.基层医疗医生使用的神经运动障碍INCLEN诊断工具(INDT-NMI):开发与验证
Indian Pediatr. 2014 Aug;51(8):613-9. doi: 10.1007/s13312-014-0463-3.
4
Evaluation of AIIMS Modified INCLEN Tool for Diagnosis of Epilepsy.评估全印度医学科学研究所(AIIMS)改良的国际临床流行病学网络(INCLEN)癫痫诊断工具。
Indian Pediatr. 2023 Jan 15;60(1):45-48. Epub 2022 Oct 29.
5
The Development and Validation of DSM 5-Based AIIMS-Modified INDT ADHD Tool for Diagnosis of ADHD: A Diagnostic Test Evaluation Study.基于 DSM-5 的 AIIMS 改良 INDT ADHD 工具的制定与验证:用于 ADHD 诊断的诊断测试评估研究。
Neurol India. 2020 Mar-Apr;68(2):352-357. doi: 10.4103/0028-3886.280638.
6
INCLEN Diagnostic Tool for Epilepsy (INDT-EPI) for primary care physicians: development and validation.基层医疗医生使用的癫痫INCLEN诊断工具(INDT-EPI):开发与验证
Indian Pediatr. 2014 Jul;51(7):539-43. doi: 10.1007/s13312-014-0443-7.
7
Development and validation of DSM-5 based diagnostic tool for children with Autism Spectrum Disorder.基于 DSM-5 的自闭症谱系障碍儿童诊断工具的开发和验证。
PLoS One. 2019 Mar 13;14(3):e0213242. doi: 10.1371/journal.pone.0213242. eCollection 2019.
8
INCLEN Diagnostic Tool for Autism Spectrum Disorder (INDT-ASD): development and validation.自闭症谱系障碍INCLEN诊断工具(INDT-ASD):开发与验证
Indian Pediatr. 2014 May;51(5):359-65. doi: 10.1007/s13312-014-0417-9.
9
Diagnostic Accuracy of International Epidemiology Network (INCLEN) Diagnostic Tool for Autism Spectrum Disorder (INDT-ASD) in Comparison with Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5).国际流行病学网络自闭症谱系障碍诊断工具(INDT-ASD)与《精神疾病诊断与统计手册》第5版(DSM-5)相比的诊断准确性。
Indian Pediatr. 2018 Jun 15;55(6):482-484.
10
INCLEN diagnostic tool for attention deficit hyperactivity disorder (INDT-ADHD): development and validation.注意力缺陷多动障碍的INCLEN诊断工具(INDT-ADHD):开发与验证
Indian Pediatr. 2014 Jun;51(6):457-62. doi: 10.1007/s13312-014-0436-6.

本文引用的文献

1
INCLEN Diagnostic Tool for Neuromotor Impairments (INDT-NMI) for primary care physician: development and validation.基层医疗医生使用的神经运动障碍INCLEN诊断工具(INDT-NMI):开发与验证
Indian Pediatr. 2014 Aug;51(8):613-9. doi: 10.1007/s13312-014-0463-3.
2
Development and validation of Trivandrum Development Screening Chart for children aged 0-6 years [TDSC (0-6)].特兰奎巴发展筛查图表(0-6 岁)在 0-6 岁儿童中的制定与验证[TDSC(0-6)]。
Indian J Pediatr. 2013 Nov;80 Suppl 2:S248-55. doi: 10.1007/s12098-013-1144-2. Epub 2013 Sep 8.
3
Predicting neurodevelopmental outcomes for at-risk infants: reliability and predictive validity using a Chinese version of the INFANIB at 3, 7 and 10 months.
预测高危婴儿的神经发育结局:使用中文版 INFANIB 在 3、7 和 10 个月时的信度和预测效度。
BMC Pediatr. 2012 Jun 14;12:72. doi: 10.1186/1471-2431-12-72.
4
Ages and Stages Questionnaire as a screening tool for developmental delay in Indian children. Ages and Stages Questionnaire 作为一种筛查印度儿童发育迟缓的工具。
Indian Pediatr. 2012 Jun;49(6):457-61. doi: 10.1007/s13312-012-0074-9. Epub 2011 Oct 30.
5
An algorithm for identifying and classifying cerebral palsy in young children.一种用于识别和分类幼儿脑瘫的算法。
J Pediatr. 2008 Oct;153(4):466-72. doi: 10.1016/j.jpeds.2008.04.013. Epub 2008 Jun 2.
6
Developmental potential in the first 5 years for children in developing countries.发展中国家儿童头五年的发育潜力。
Lancet. 2007 Jan 6;369(9555):60-70. doi: 10.1016/S0140-6736(07)60032-4.
7
A random sample survey for prevalence of major neurological disorders in Kolkata.加尔各答主要神经系统疾病患病率的随机抽样调查。
Indian J Med Res. 2006 Aug;124(2):163-72.
8
The descriptive epidemiology of cerebral palsy.脑瘫的描述性流行病学
Clin Perinatol. 2006 Jun;33(2):251-67. doi: 10.1016/j.clp.2006.03.011.
9
Cerebral palsy-definition, classification, etiology and early diagnosis.脑瘫——定义、分类、病因及早期诊断
Indian J Pediatr. 2005 Oct;72(10):865-8. doi: 10.1007/BF02731117.
10
Specialty care by child neurologists: a workforce analysis.儿童神经科医生的专科护理:劳动力分析。
Neurology. 2005 Mar 22;64(6):942-8. doi: 10.1212/01.WNL.0000154462.34536.CB.